Kidney Disease Testing Methods Found Equal
New research shows two common urinary protein tests provide indistinguishable prognostic information for patients.
Updated on Sept. 25, 2026 in Heart Disease
Live Poll
Do you trust that different diagnostic tests for kidney disease are equally reliable for your health?
Researchers have determined that urinary albumin-creatinine ratio and urinary protein-creatinine ratio offer the same level of prognostic insight for chronic kidney disease. This finding comes from an analysis of 3,742 participants followed over a median of 15.0 years.
Why it matters
Determining that these testing methods yield equivalent results allows clinicians to potentially standardize diagnostic approaches. This simplifies assessment protocols for patients monitoring their risk of kidney failure and cardiovascular events.
A study of 3,742 participants showed a 32.3 percent rate of kidney failure and a 31.5 percent rate of cardiovascular composite events over 15.0 years. The five-year area under the curve reached 0.894 for UACR and 0.899 for UPCR.
The players
Boston University Chobanian & Avedisian School of Medicine
This institution served as the research base for the study regarding chronic kidney disease markers.
Chronic Renal Insufficiency Cohort Study
This longitudinal study provided the database of 3,742 participants used to evaluate the diagnostic ratios.
The details
Researchers at the Boston University Chobanian & Avedisian School of Medicine evaluated paired samples from 24-hour collections. The study assessed long-term outcomes, including kidney failure, disease progression, and composite cardiovascular events like stroke or myocardial infarction.
Timeline
A research letter detailing the findings was published on September 23, 2026.
The Big Picture
This research follows the established longitudinal framework of the Chronic Renal Insufficiency Cohort Study to refine diagnostic precision. It extends the utility of existing testing benchmarks by confirming the interchangeable nature of two standard laboratory metrics.
Patients may benefit from more consistent diagnostic standards that reduce ambiguity in long-term health monitoring. These findings support streamlined routine care by confirming that clinicians can rely on either method to accurately assess their risk profile.
The takeaway
Standardizing these tests helps doctors provide more reliable long-term prognostic feedback to patients. Individuals should consult their healthcare provider to discuss which testing markers are appropriate for their specific kidney health plan.
Further reading
Learn more about managing long-term health risks in our Heart Disease section.
Source note: This article includes information reported by Drugs.
Live Poll
Do you trust that different diagnostic tests for kidney disease are equally reliable for your health?
